# Fuse Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fuse-oncology

- Industry: Software
- Headquarters: Greensboro, US
- Website: www.fuseonc.com
- Total disclosed funding: $8.9M
- Latest round: Series A (Apr 6, 2023)
- Investors on record: 2

## About

Founded in 2021 by its CEO, James Bauler, CIO, BJ Sintay, and CTO, David Wiant, and based in North Carolina, US, Fuse Oncology, Inc., operates as software platform that uses SaaS solutions to eliminate duplicative and unnecessary data in the medical record database. In June 2023, Fuse Oncology, Inc., raised series A funding from investors Cone Health Ventures and Northeast Georgia Health Ventures. 

The company offers a digital platform used for radiation oncology processes and provide business and clinical intelligence solution that allows users to access documentation and assess data custom system configuration, recurring status checks and support, periodic, scheduled meetings to review rule breaks and ruleset accuracy, customer support provided for ad hoc questions and feature requests, and annual billing audits and updates. The company also provides automated engine and web-based insights portal to radiation oncology processes and data.

The company plans to use the June 2023 funding to further grow its product offerings in the oncology market.

## Funding rounds

- Series A, Apr 6, 2023, $8.9M — Cone Health Ventures, Northeast Georgia Health Ventures

## Investors

- Cone Health Ventures (https://capitalatlas.ai/funds/cone-health-ventures) — Series A
- Northeast Georgia Health Ventures — Series A